Characteristics of eligible studies.
- Xu Chen (432759)
- Zhe Wang (41178)
- Yulan Yan (509467)
- Ping Li (31981)
- Zheng Yang (264955)
- Lingyan Qin (509468)
- Wuning Mo (509469)
Publication date
January 2014
DOIAbstract
<p>HC, Histologically confirmed; PC, Pathologically confirmed; NR Not reported; PB, Population–based; HB, Hospital–based; HWE, Hardy–Weinberg equilibrium in control population; PCR–RFLP, Polymerase chain reaction-restriction fragment length polymorphism; PCR-SSP, Polymerase chain reaction-sequence-specific primer; BCC, basal cell carcinoma; SCC, squamous cell carcinoma.</p
Add to ORKG